Estimating Drug Requirements - A Practical Manual
(1995; 158 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPREFACE
Close this folderPART I: INTRODUCTION
Open this folder and view contentsMODULE 1: Objectives and use of the manual
Close this folderMODULE 2: Assessing the need for better quantification
Close this folder1. SYMPTOMS OF POOR QUANTIFICATION
View the document1.1 Chronic and widespread shortages
View the document1.2 Surpluses
View the document1.3 Inequity of supply
View the document1.4 Inadequate cost-effectiveness
View the document1.5 Irrational adjustments to budgetary constraints
View the document1.6 Irrational and ineffective prescribing
View the document1.7 Suppression or distortion of demand
Open this folder and view contentsMODULE 3: Preparing an action plan
Open this folder and view contentsMODULE 4: DRAWING UP AND REVIEWING ESSENTIAL DRUG LISTS BY TYPE OF FACILITY
Open this folder and view contentsPART II: THE MORBIDITY METHOD
Open this folder and view contentsPART III: THE CONSUMPTION METHOD
Open this folder and view contentsANNEXES
 

1. SYMPTOMS OF POOR QUANTIFICATION

As noted in Module 1, few countries have systematic procedures for quantifying drug requirements. This lack is particularly serious in developing countries because of their heavy dependence on imports, the need to plan orders well in advance, and the vital importance of making the best use of limited budgets and scarce foreign exchange.

The most commonly encountered symptoms of poor quantification of drug requirements are briefly described below. Of course these symptoms may be caused by several other deficiencies, but poor quantification is usually one of them and often the most important one.

to previous section to next section
 

Last updated: May 3, 2013